Joint relief
Celltech, the UK-based biotech firm, has tested a new drug against rheumatoid arthritis. Thegeneti- cally engineered drugCDP 571, is based on a synthetic antibody. The antibody blocks the action of the protein that attacks the joints of rheumatoid arthritis sufferers ( The Eastern Phannacist, Vo138, No 453). When tried on 36 patients, the ~drug mitigated the pain of affected joints and slowed the disease's progression just after eight weeks' treatment.
Related Content
- Compliance report filed by Singareni Collieries, Khammam district, Telangana, 06/10/2021
- Order of the Supreme Court regarding protection of forest officers and staff, 08/01/2021
- Order of the National Green Tribunal regarding untreated effluents from industries affecting water quality, Zahirabad, Sangareddy District, Telangana, 08/08/2019
- Order of the National Green Tribunal regarding closure of TSDF established by M/s Ramky Enviro Engineers, Karnataka, 22/04/2019
- Order of the National Green Tribunal regarding leather industries causing pollution to river Ganga, Jajmau Kanpur, Uttar Pradesh, 14/01/2016
- Nepal State of Environment Report: The Monthly Overview, November, 2014